Navigation Links
OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences
Date:9/3/2009

BOTHELL, WA and VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the company will webcast presentations at the following investor conferences:

    -   Rodman & Renshaw 11th Annual Healthcare Conference on Thursday,
        September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon
        at the New York Palace Hotel in New York City.

    -   Thomas Weisel Partners Healthcare Conference on Friday, September 11,
        2009 at 10:20 a.m. Eastern Time in the Stuart Room at the Four
        Seasons Hotel in Boston.

    -   BioCentury NewsMakers in the Biotech Industry Conference on
        Wednesday, September 16, 2009 at 2:30 p.m. Eastern Time in room
        304/305 at the Millennium Broadway Hotel & Conference Center in New
        York City.

Access to a live webcast of each of the presentations will be available on the Events Presentation section of the Investor Relations page on the company Web site at www.oncogenex.com. A replay of each webcast will be available for 30 days following the event.

About OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate that has completed five Phase 2 clinical studies in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 is in Phase 1 clinical develo
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 The ... opening of two new offices in Asia—one in Singapore ... will serve as RAPS’ Pan-Asia office , serving ... be more focused on audiences within China. , The ... its partnership with five Singapore government agencies to develop ...
(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...
(Date:6/18/2013)... The "Bioinformatics Market By Sector (Molecular Medicine, ... & Data Analysis Services) & Application (Genomics, Proteomics & Drug ... Drivers, Restraints, and Opportunities in North America ... and Rest of World. Browse ... 22 Figures 364 Pages and an ...
(Date:6/18/2013)... June 18, 2013 ... announced the addition of the "Injectable ... & Nanoparticles], Devices [Disposables & Reusable, Fillable ... Injectors] & Therapeutics [Diabetes & Oncology] - ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ...
Breaking Biology Technology:RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... and will be integrated into ... the deCODEme(TM) service, REYKJAVIK, ... problem that contributes to millions of,deaths around the world each year. ... known about why some people are,particularly likely to get addicted to ...
... Sciences Corporation announced,today the launch of the ... ). During the past two years, IC ... launched membership program,such as scientific tools, industry ... instruments for professional, consumer, and,therapeutics medical market ...
... 2, 2008 PAREXEL International,Corporation (Nasdaq: ... today announced that Larry Ereshefsky, Pharm.D., F.C.C.P.,B.C.C.P., ... as Vice Presidents,of Clinical Pharmacology Consulting Services ... leading experts advise clients on,early phase clinical ...
Cached Biology Technology:A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease 2A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease 3A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease 4IC Sciences Launches ICS Alliance to Advance Development and Adoption of Informatics Instruments for Next Generation Healthcare 2PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 2PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 3PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 4PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 5
(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...
(Date:6/17/2013)... and a major cause is a deadly fungus thought ... shows they can also die from this pathogen, contrary ... that just spreads the disease. , When researchers raised ... found at least one strain of this pathogen, ... fungus, can be fatal to year-old juveniles. However, bullfrogs ...
(Date:6/16/2013)... sex workers in India reduce rates of syphilis, HIV ... Toronto study has found. , About two ... southern states of Andhra Pradesh, Karnataka, Maharashtra and Tamil ... U of T,s Dalla Lana School of Public Health ... (CGHR), examined the impact of prevention among female sex ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2HIV prevention among female sex workers in India reduces HIV and syphilis 2
... proteins has been found to constitute one of the ... have discovered. The engineers and biologists from Duke University ... could lead to a new understanding of mechanical processes ... potent nanoscale "shock absorbers" or "gate-opening springs" in tiny ...
... Rutgers researchers have found that the curry spice ... prevention of prostate cancer, particularly when combined with ... known as curcumin, along with phenethyl isothiocyanate (PEITC), ... group of vegetables that includes watercress, cabbage, winter ...
... an uncanny ability to skim through text, instantly recognizing ... 6000 years ago--long after humans evolved. Thus, neuroscientists ... called the Visual Word Form Area (VWFA) is truly ... Functional MRI scans have shown that the area specifically ...
Cached Biology News:Protein 'nanosprings' most resilient found in nature 2Protein 'nanosprings' most resilient found in nature 3Protein 'nanosprings' most resilient found in nature 4Curry and cauliflower could halt prostate cancer 2'Word-vision' brain area confirmed 2
RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Request Info...
Request Info...
Biology Products: